Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Kidney Cancer treatment details. Biologic therapy. Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Survival: N/R
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: New York, New York
Hospital: Memorial Sloan-Kettering Cancer Center
Journal: Link
Date: 2/2003

Patients: This Phase II study involved 54 patients with metastatic renal cell carcinoma; 44 men and 10 women. The average age was 59. Thirty-seven patients had undergone a prior nephrectomy. The average time from time of original diagnosis to the start of this treatment was 22.5 months.

Treatment: The treatment consisted of the administration of Cetuximab, a monoclonal antibody.

Toxicity: Grade 3-4 toxicities included asthenia, back pain, heart failure, anemia, lung edema, acne, skin rash, and dry skin.

Results: There were no complete or partial responses.

Correspondence: Robert J. Motzer, MD

E-mail to a Friend Email Physician More Information